TransCode Therapeutics, Inc. (RNAZ) SEC EDGAR filings (10-Q, 8-K, DEF 14A, S-1, 10-K/A, 10-K), newest first; latest 10-Q filed 2026-08-14. Every filing links to the canonical SEC document. First-party data.
| Filed | Form | Title |
|---|---|---|
| 2026-08-14 | 10-Q | 10-Q filed 2026-08-14 by Transcode Therapeutics, Inc. |
| 2026-08-03 | 8-K | 8-K filed 2026-08-03 by Transcode Therapeutics, Inc. |
| 2026-07-20 | 8-K | 8-K filed 2026-07-20 by Transcode Therapeutics, Inc. |
| 2026-06-02 | DEF 14A | DEF 14A filed 2026-06-02 by Transcode Therapeutics, Inc. |
| 2026-05-15 | 10-Q | 10-Q filed 2026-05-15 by Transcode Therapeutics, Inc. |
| 2026-05-01 | S-1 | S-1 filed 2026-05-01 by Transcode Therapeutics, Inc. |
| 2026-04-30 | 10-K/A | 10-K/A filed 2026-04-30 by Transcode Therapeutics, Inc. |
| 2026-04-15 | 10-K | 10-K filed 2026-04-15 by Transcode Therapeutics, Inc. |
| 2025-11-14 | 10-Q | 10-Q filed 2025-11-14 by Transcode Therapeutics, Inc. |
| 2025-07-15 | DEF 14A | DEF 14A filed 2025-07-15 by Transcode Therapeutics, Inc. |
| 2024-12-06 | S-1 | S-1 filed 2024-12-06 by Transcode Therapeutics, Inc. |
RNAZ overview · RNAZ earnings · RNAZ financials · RNAZ KPIs · RNAZ investor relations · RNAZ ownership · RNAZ peers
Data sourced from U.S. SEC EDGAR. Not personalized investment advice.